Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies ...

What a pity that a Republican administration needs to be reminded that this misguided policy won’t make America healthy or great.

Regeneron bids for 23andMe at a discounted price of $256 million. The testing firm was once valued at $3.5 billion.

The FDA greenlit marketing for the first blood test to help diagnose Alzheimer’s disease. Experts believe this will increase ...

Laminin 521 (Cat. No. GMP-LA5H24) successfully maintained rapid expansion of human iPSCs, enabling cell passaging after just ...

For decades, scientists and surgeons around the world have been trying to solve the organ donor crisis. The answer could be ...

Three-dimensional printing is transforming medical care, letting the health care field shift from mass-produced solutions to ...

Antimicrobial-resistant (AMR) “superbugs” contribute to more than 4.5 million deaths globally per year and threaten to make ...

Modern healthcare is increasingly reliant on genetic testing. Its significance is at an all-time high due to its applications ...

Artificial intelligence is revolutionizing the way we care for animals. Once limited to reactive treatments at vet clinics, animal healthcare is evolving into a proactive, data-driven field where AI ...

The pharmaceutical industry's patience is wearing thin with the Trump administration's pressure. But the administration doesn ...

Aksh Ladegaonkar , a sophomore at International Baccalaureate at Bartow High School, earned second place in the Dr. Nelson ...